Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03664895` - Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)	Phase 3
Recruiting	`NCT05505357` - Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)	N/A
Completed	`NCT03669705` - No Axillary Surgery for Early Breast Cancer.
Terminated	`NCT05012397` - Milademetan in Advanced/Metastatic Solid Tumors	Phase 2
Recruiting	`NCT05877859` - Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Active, not recruiting	`NCT04398914` - Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer	Phase 2
Recruiting	`NCT05351424` - AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc	N/A
Active, not recruiting	`NCT03627988` - Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.	Phase 2
Completed	`NCT05300412` - The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer
Recruiting	`NCT04999917` - Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer	N/A
Completed	`NCT05019989` - Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study	N/A
Recruiting	`NCT06144944` - Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer	Phase 3
Recruiting	`NCT04891068` - BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer	Phase 2
Recruiting	`NCT05939310` - Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study	N/A
Recruiting	`NCT06401304` - Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
Not yet recruiting	`NCT06268665` - Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy	Phase 2
Completed	`NCT05463276` - The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Completed	`NCT04729647` - Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer	N/A
Active, not recruiting	`NCT06234488` - Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Recruiting	`NCT00437879` - Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.

NCT number	NCT05910398
Study type	Interventional
Source	RenJi Hospital
Contact	Wenjin Yin, M.D.
Phone	86(21)58852345
Email	yinwenjin@renji.com
Status	Recruiting
Phase	Phase 3
Start date	June 1, 2023
Completion date	August 2030

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer — CORINNE-PI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms